Saffwell® Gummies

Saffwell® Gummies are manufactured in GMP certified facilities and meet strict safety and quality standards through third party testing. We recommend consulting your healthcare provider if you have specific health conditions or are taking medications. Pregnant women should avoid saffron-containing products.

Many people notice subtle calm and focus within the first week. More consistent mood and wellness benefits are typically seen after 2–4 weeks of daily use.

Saffron has been studied for mood, stress, attention, and women’s health — including trials comparing it to standard treatments for depression, ADHD, and PMS. See our blogs for more detail.

Saffron has been used for centuries as a wellness botanical, and in recent decades, its benefits have been confirmed in modern clinical studies. Research highlights saffron’s ability to support mood, focus, and women’s health — with results often comparable to conventional treatments, but without common side effects. 

What makes saffron unique is the consistency of results across studies: whether compared to placebo or even standard medications (like SSRIs for depression or stimulants for ADHD), saffron has often shown comparable benefits with fewer reported side effects.

By highlighting the clinical evidence, Saffwell® Gummies aren’t just part of a wellness ritual — they stand on the shoulders of a growing body of scientific research.

Mood & Emotional Health

Jackson et al. (2021) — Saffron & Subclinical Mood in Healthy Adults

• In a double-blind RCT, 56 healthy adults (ages 18–54) with mild mood or stress symptoms received 30 mg standardized saffron extract over 8 weeks. Frontiers+1

• Results: participants reported lower depression scores, improved social relationships, and reduced stress reactivity. The study also noted that saffron moderated the usual drop in heart rate variability under stress (i.e. supported resilience). Frontiers+1

Systematic Review / Meta-Analysis: Saffron vs SSRIs / Placebo

• A meta-analysis in Nutrition Reviews looked at RCTs comparing saffron to SSRIs (selective serotonin reuptake inhibitors) for depression and anxiety. It found no significant difference between saffron and SSRIs in reducing depressive symptoms (SMD ~0.10, 95% CI: –0.09 to 0.29), and fewer adverse events in saffron groups. Oxford Academic

• Another systematic review analyzing RCTs across general and clinical populations found saffron significantly reduced symptoms of depression and anxiety compared to placebo. Oxford Academic

ADHD & Cognitive Focus

Pazoki et al. (2022) — Saffron as Adjunctive Therapy in Adults with ADHD

• This randomized, double-blind, placebo-controlled trial added saffron to standard treatment for adults with ADHD to test whether saffron could enhance symptom improvement. ScienceDirect

• While results are preliminary, the saffron + standard therapy group showed improvements in attention and hyperactivity, relative to control groups. ScienceDirect

Pediatric / Adolescent Pilot Studies

• A pilot clinical study compared saffron extract (Saffr’Activ®) to methylphenidate in children/adolescents with ADHD. The results suggested comparable efficacy on core ADHD symptoms, with saffron performing better on hyperactivity and promoting sleep onset more easily. ResearchGate

• In a combined therapy trial, adding saffron to methylphenidate in kids with ADHD led to more rapid symptom reduction than methylphenidate alone. nutrimindlab.com+1

• Regulatory sources (e.g. Medical News Today) also note that saffron may reduce hyperactivity symptoms in ADHD, though evidence is limited and short-term. Medical News Today

PMS / Women’s Wellness

Meta-Analysis: Saffron & PMS

• A recent meta-analysis (2025) reviewed clinical trials using saffron for PMS. They found a statistically significant mean difference favoring saffron interventions vs. placebo (mean difference 0.63; 95% CI [1.18 – 0.07], p = 0.03) in symptom severity. rcm.mums.ac.ir

• The authors caution, however, that many included trials had methodological weaknesses (small sample sizes, risk of bias) and call for better-designed large trials. rcm.mums.ac.ir

HumanClinical Database Entry

• According to a clinical database listing “Human Clinical Studies on Saffron,” saffron demonstrated efficacy for emotional PMS symptoms (irritability, mood swings, depression) in double-blind, placebo-controlled trials measuring PMS via the Daily Symptom Report and Hamilton Depression Rating Scale. humanclinicals.org

Mechanisms & Bioactives

• Saffron’s active compounds (crocin, safranal) are believed to modulate serotonin, dopamine, and norepinephrine pathways, similarly to how SSRIs and antidepressants work, but via natural bioactive routes. thehumanfuture.org+2Genetic Lifehacks+2

• As antioxidants and anti-inflammatory agents, saffron may reduce oxidative stress, which is implicated in mood disorders and neurocognitive decline. ScienceDirect+2Genetic Lifehacks+2

Safety, Dosage, Limitations & Future Directions

• Many clinical trials used ~30 mg/day saffron extract (often in two divided doses). Frontiers+2Oxford Academic+2

• The meta-analysis comparing saffron vs SSRIs found fewer adverse events in saffron groups. Oxford Academic

• A broader meta-research review notes that saffron is generally considered safe in these doses, but calls for higher-quality, large-scale RCTs across various populations to validate and expand the evidence base. ScienceDirect

References

1. Jackson, P.A., et al. (2021). Effects of Saffron Extract Supplementation on Mood, Well-Being, and Response to a Laboratory Stressor in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Study. Frontiers in Nutrition, 7:606124. Link

2. Lopresti, A.L., et al. (2019). Saffron for depression and anxiety: A systematic review and meta-analysis. Nutrition Reviews, 77(8): 557–571. Link

3. Rahemi, Z., et al. (2023). Efficacy of saffron supplementation in patients with major depressive disorder: A systematic review and meta-analysis of randomized controlled trials. Nutrition Reviews, 83(3): e751–e764. Link

4. Pazoki, M., et al. (2022). Saffron as an adjunctive therapy in adults with attention-deficit/hyperactivity disorder: A randomized, double-blind, placebo-controlled clinical trial. Journal of Affective Disorders, 303: 16–22. Link

5. Baziar, S., et al. (2019). Comparing saffron and methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder: A randomized, double-blind clinical trial. Journal of Child and Adolescent Psychopharmacology, 29(2): 130–136.

6. Agha-Hosseini, M., et al. (2008). Saffron in the treatment of premenstrual syndrome: A randomized double-blind placebo-controlled trial. International Journal of Obstetrics and Gynecology, 108(2): 175–180.

7. Abed, A., et al. (2025). The Effect of Saffron on Premenstrual Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Reviews in Clinical Medicine, 12(1): 1–10. Link

8. Milajerdi, A., et al. (2021). Saffron supplementation and health outcomes: A comprehensive systematic review and dose-response meta-analysis of randomized controlled trials. Pharmacological Research, 170: 105689. Link

Unlike capsules or powders, Saffwell® Gummies combine clinically studied saffron with Manuka honey, wildflower honey, and Damask rose for a ritual that’s as enjoyable as it is effective. T

Yes, this supplement is safe for children and great for mood and attention. Always check with your healthcare provider before starting a new supplement.

We have consciously used miron glass jars in order to maintain the highest potency of our products. To ensure the freshness and effectiveness of our products, store them in a cool, dry place away from direct sunlight. Always keep them out of reach of children.

We offer a 30-day satisfaction guarantee. If you're not completely happy with your purchase, you can return it for a refund or exchange. Please visit our Return Policy page for more details.